610
Views
1
CrossRef citations to date
0
Altmetric
Commentaries

The appropriate clinical use of niacin in the treatment of dyslipidemia

, &
Pages 17-22 | Published online: 18 Jan 2017
 

Abstract

“The claim that HPS2 THRIVE proved that niacin induced more adverse effects than the statin arm of the study is not supported by the data.”

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.